QQQ   359.88 (-2.83%)
AAPL   142.06 (-2.28%)
MSFT   284.98 (-3.12%)
FB   340.06 (-3.82%)
GOOGL   2,709.04 (-3.98%)
TSLA   778.07 (-1.68%)
AMZN   3,296.95 (-3.20%)
NVDA   207.01 (-4.43%)
BABA   150.32 (+0.09%)
NIO   35.16 (-4.38%)
CGC   14.19 (-3.54%)
GE   105.19 (-0.15%)
MU   73.42 (-2.34%)
AMD   102.44 (-5.29%)
T   27.22 (-0.66%)
F   14.37 (+1.48%)
ACB   6.75 (+5.63%)
DIS   174.20 (-2.28%)
PFE   42.84 (-1.68%)
BA   218.59 (-2.48%)
AMC   37.49 (-4.61%)
QQQ   359.88 (-2.83%)
AAPL   142.06 (-2.28%)
MSFT   284.98 (-3.12%)
FB   340.06 (-3.82%)
GOOGL   2,709.04 (-3.98%)
TSLA   778.07 (-1.68%)
AMZN   3,296.95 (-3.20%)
NVDA   207.01 (-4.43%)
BABA   150.32 (+0.09%)
NIO   35.16 (-4.38%)
CGC   14.19 (-3.54%)
GE   105.19 (-0.15%)
MU   73.42 (-2.34%)
AMD   102.44 (-5.29%)
T   27.22 (-0.66%)
F   14.37 (+1.48%)
ACB   6.75 (+5.63%)
DIS   174.20 (-2.28%)
PFE   42.84 (-1.68%)
BA   218.59 (-2.48%)
AMC   37.49 (-4.61%)
QQQ   359.88 (-2.83%)
AAPL   142.06 (-2.28%)
MSFT   284.98 (-3.12%)
FB   340.06 (-3.82%)
GOOGL   2,709.04 (-3.98%)
TSLA   778.07 (-1.68%)
AMZN   3,296.95 (-3.20%)
NVDA   207.01 (-4.43%)
BABA   150.32 (+0.09%)
NIO   35.16 (-4.38%)
CGC   14.19 (-3.54%)
GE   105.19 (-0.15%)
MU   73.42 (-2.34%)
AMD   102.44 (-5.29%)
T   27.22 (-0.66%)
F   14.37 (+1.48%)
ACB   6.75 (+5.63%)
DIS   174.20 (-2.28%)
PFE   42.84 (-1.68%)
BA   218.59 (-2.48%)
AMC   37.49 (-4.61%)
QQQ   359.88 (-2.83%)
AAPL   142.06 (-2.28%)
MSFT   284.98 (-3.12%)
FB   340.06 (-3.82%)
GOOGL   2,709.04 (-3.98%)
TSLA   778.07 (-1.68%)
AMZN   3,296.95 (-3.20%)
NVDA   207.01 (-4.43%)
BABA   150.32 (+0.09%)
NIO   35.16 (-4.38%)
CGC   14.19 (-3.54%)
GE   105.19 (-0.15%)
MU   73.42 (-2.34%)
AMD   102.44 (-5.29%)
T   27.22 (-0.66%)
F   14.37 (+1.48%)
ACB   6.75 (+5.63%)
DIS   174.20 (-2.28%)
PFE   42.84 (-1.68%)
BA   218.59 (-2.48%)
AMC   37.49 (-4.61%)
NASDAQ:RDHL

RedHill Biopharma SEC Filings & 10K Form

$4.85
-0.29 (-5.64 %)
(As of 09/28/2021 12:57 PM ET)
Add
Compare
Today's Range
$4.84
$5.20
50-Day Range
$4.55
$10.36
52-Week Range
$4.48
$11.52
Volume15,715 shs
Average Volume564,898 shs
Market Capitalization$226.33 million
P/E RatioN/A
Dividend YieldN/A
Beta1.47

RedHill Biopharma (NASDAQ:RDHL) SEC Filings

DateFilerForm TypeView
09/14/2021
7:18 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2021
6:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/07/2021
6:04 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/07/2021
5:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/02/2021
9:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2021
6:01 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2021
5:04 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/23/2021
6:02 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2021
6:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2021
11:15 PM
RedHill Biopharma (Filer)
Form EFFECT
07/26/2021
8:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/20/2021
6:02 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/19/2021
6:06 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2021
6:01 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2021
6:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2021
8:11 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/10/2021
7:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2021
6:01 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/07/2021
6:05 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2021
3:02 PM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2021
11:28 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/20/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/03/2021
8:06 AM
RedHill Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/26/2021
5:30 AM
RedHill Biopharma (Subject)
Form SC TO-I
04/09/2021
6:04 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2021
11:15 PM
RedHill Biopharma (Filer)
Form EFFECT
04/08/2021
3:38 PM
RedHill Biopharma (Filer)
Form 424B3
03/30/2021
7:00 AM
RedHill Biopharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
03/25/2021
8:30 AM
RedHill Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2021
8:27 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2021
6:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2021
6:00 AM
RedHill Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/18/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/05/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2021
8:19 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/02/2021
7:26 AM
RedHill Biopharma (Subject)
Form FWP
03/01/2021
4:02 PM
RedHill Biopharma (Subject)
Form FWP
03/01/2021
3:59 PM
RedHill Biopharma (Subject)
Form FWP
02/23/2021
6:10 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/17/2021
6:09 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/02/2021
7:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/29/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/28/2021
6:31 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/15/2021
10:19 AM
Ibex Investors LLC (Filed by)
RedHill Biopharma (Subject)
Form SC 13G/A
01/14/2021
1:28 PM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/14/2021
8:21 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/13/2021
4:09 PM
RedHill Biopharma (Filer)
Form 424B5
01/12/2021
7:56 AM
RedHill Biopharma (Subject)
Form FWP
01/11/2021
3:54 PM
RedHill Biopharma (Subject)
Form FWP
01/11/2021
3:52 PM
RedHill Biopharma (Subject)
Form FWP
01/11/2021
3:47 PM
RedHill Biopharma (Filer)
Form 424B5
01/11/2021
3:45 PM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/11/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/06/2021
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/31/2020
8:30 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/22/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/15/2020
8:30 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2020
7:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/25/2020
9:42 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/23/2020
7:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2020
7:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/19/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/17/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2020
9:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/12/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/05/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2020
9:30 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/26/2020
9:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/26/2020
8:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/14/2020
10:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/13/2020
9:30 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2020
9:30 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/07/2020
9:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/22/2020
9:08 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/22/2020
6:14 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/15/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/08/2020
7:30 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2020
6:06 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/27/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2020
6:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2020
5:10 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2020
10:28 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/06/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/05/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/03/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/30/2020
6:03 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2020
8:44 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/27/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/23/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2020
6:00 AM
RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.